Agency Information Collection Activities, 25769-25770 [E8-10082]

Download as PDF sroberts on PROD1PC70 with NOTICES Federal Register / Vol. 73, No. 89 / Wednesday, May 7, 2008 / Notices the matter can be obtained by contacting the Commission’s TDD terminal on 202– 205–1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on March 23, 2006, based on a complaint filed by Epson Portland, Inc. of Oregon; Epson America, Inc. of California; and Seiko Epson Corporation of Japan (collectively ‘‘Epson’’). 71 FR 14720 (March 23, 2006). The complaint, as amended, alleged violations of section 337 of the Tariff Act of 1930 (‘‘section 337’’) in the importation into the United States, the sale for importation, and the sale within the United States after importation of certain ink cartridges and components thereof by reason of infringement of claim 7 of U.S. Patent No. 5,615,957; claims 18, 81, 93, 149, 164 and 165 of U.S. Patent No. 5,622,439; claims 83 and 84 of U.S. Patent No. 5,158,377; claims 19 and 20 of U.S. Patent No. 5,221,148; claims 29, 31, 34 and 38 of U.S. Patent No. 5,156,472; claim 1 of U.S. Patent No. 5,488,401; claims 1–3 and 9 of U.S. Patent No. 6,502,917; claims 1, 31 and 34 of U.S. Patent No. 6,550,902; claims 1, 10 and 14 of U.S. Patent No. 6,955,422; claim 1 of U.S. Patent No. 7,008,053; and claims 21, 45, 53 and 54 of U.S. Patent No. 7,011,397. The complaint further alleged that an industry in the United States exists as required by subsection (a)(2) of section 337. The complainants requested that the Commission issue a general exclusion order and cease and desist orders. The Commission named as respondents 24 companies located in China, Germany, Hong Kong, Korea, and the United States. Several respondents were terminated from the investigation on the basis of settlement agreements or consent orders or were found in default. On March 30, 2007, the presiding ALJ (Judge Luckern) issued a final ID in the investigation finding a violation of section 337 with respect to certain respondents. He found the asserted claims valid and infringement by certain respondents’ products. He recommended issuance of a general exclusion order and cease and desist orders directed to certain respondents and bond in the amount of $13.60 per cartridge during the Presidential review period. On October, 19, 2007, after review, the Commission made its final determination in the investigation, finding a violation of section 337. The Commission issued a general exclusion order, limited exclusion order, and cease and desist orders directed to several domestic respondents. The Commission also determined that the VerDate Aug<31>2005 21:00 May 06, 2008 Jkt 214001 public interest factors enumerated in 19 U.S.C. 1337(d), (f), and (g) did not preclude issuance of the aforementioned remedial orders, and that the bond during the Presidential review period would be $13.60 per cartridge for covered ink cartridges. On February 8, 2008, complainant Epson filed two complaints seeking enforcement proceedings under Commission Rule 210.75. One complaint alleges that Ninestar Technology Co., Ltd.; Ninestar Technology Company, Ltd.; and Town Sky Inc. have violated the general exclusion order and that Ninestar Technology Company, Ltd. and Town Sky Inc. have violated the cease and desist orders directed to them. Epson’s second complaint alleges that Mipo International Ltd. and Mipo America, Ltd. have violated the general and limited exclusion orders and that Mipo America, Ltd. has violated the cease and desist order directed to it. Having examined the complaints seeking a formal enforcement proceeding, and having found that the complaints comply with the requirements for institution of a formal enforcement proceeding contained in Commission rule 210.75, the Commission has determined to institute a consolidated formal enforcement proceeding to determine whether the five respondents are in violation of the Commission’s exclusion orders and cease and desist orders issued in the investigation, and what, if any, enforcement measures are appropriate. The following entities are named as parties to the formal enforcement proceeding: (1) Complainant Epson, (2) respondents (Ninestar Technology Co., Ltd.; Ninestar Technology Company, Ltd.; Town Sky Inc.; Mipo America Ltd., and Mipo International, Ltd.) and (3) a Commission investigative attorney to be designated by the Director, Office of Unfair Import Investigations. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in section 210.75 of the Commission’s Rules of Practice and Procedure (19 CFR 210.75). Issued: May 1, 2008. By order of the Commission. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. E8–9984 Filed 5–6–08; 8:45 am] BILLING CODE 7020–02–P PO 00000 Frm 00129 Fmt 4703 Sfmt 4703 25769 DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0010] Agency Information Collection Activities 30-day notice of information collection under review. ACTION: Proposed collection; comments requested: U.S. Official Order Forms for Schedule I and II Controlled Substances (Accountable Forms), Order Form Requisition—DEA Form 222 and 222a The Department of Justice (DOJ), Drug Enforcement Administration (DEA) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 73, Number 42, page 11443 on March 3, 2008, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until June 6, 2008. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to (202) 395–5806. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and E:\FR\FM\07MYN1.SGM 07MYN1 25770 Federal Register / Vol. 73, No. 89 / Wednesday, May 7, 2008 / Notices Dated: May 2, 2008. Lynn Bryant, Department Clearance Officer, PRA, U.S. Department of Justice. [FR Doc. E8–10082 Filed 5–6–08; 8:45 am] Overview of This Information Collection sroberts on PROD1PC70 with NOTICES —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Drug Enforcement Administration 21:00 May 06, 2008 Jkt 214001 DEPARTMENT OF JUSTICE [OMB Number 1117–0021] (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: U.S. Official Order Forms for Schedule I and II Controlled Substances (Accountable Forms), Order Form Requisition (DEA Form 222 and 222a). (3) Agency form number, if any, and the applicable component of the Department sponsoring the collection: Form number: DEA Form 222 and 222a. Component: Office of Diversion Control, Drug Enforcement Administration, Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: Not-for-profit, State, local or tribal government. Abstract: DEA–222 is used to transfer or purchase Schedule I and II controlled substances and data are needed to provide an audit of transfer and purchase. DEA–222a Requisition Form is used to obtain the DEA–222 Order Form. Persons may also digitally sign and transmit orders for controlled substances electronically, using a digital certificate. Orders for Schedule I and II controlled substances are archived and transmitted to DEA. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: DEA estimates that 96,280 registrants submit forms annually for this collection, taking an estimated 13.34 hours annually. (6) An estimate of the total public burden (in hours) associated with the collection: DEA estimates that there will be 1,283,935 annual burden hours associated with the collection. If additional information is required contact: Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, NW., Washington, DC 20530. VerDate Aug<31>2005 BILLING CODE 4410–09–P Agency Information Collection Activities: Proposed Collection; Comments Requested 30-day notice of information collection under review: Records and Reports of Registrants. ACTION: The Department of Justice (DOJ), Drug Enforcement Administration (DEA) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 73, Number 42, pages 11443–11444 on March 3, 2008, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until June 6, 2008. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to (202) 395–5806. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the PO 00000 Frm 00130 Fmt 4703 Sfmt 4703 methodology and assumptions used; Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Records and Reports of Registrants. (3) Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: Form Number: None. Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: Not-for-profit institutions, federal government, state, local or tribal government. Abstract: This information is needed to maintain a closed system of distribution by requiring the individual practitioner to keep records of the dispensing and administration of controlled substances. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: DEA estimates that 103,000 respondents, with 103,000 responses annually to this collection. DEA estimates that it takes 30 minutes per year for each practitioner to maintain the necessary records. (6) An estimate of the total public burden (in hours) associated with the collection: This information collection creates an annual burden of 51,500 hours. If additional information is required contact: Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, NW., Washington, DC 20530. Dated: May 2, 2008. Lynn Bryant, Department Clearance Officer, PRA, U.S. Department of Justice. [FR Doc. E8–10084 Filed 5–6–08; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\07MYN1.SGM 07MYN1

Agencies

[Federal Register Volume 73, Number 89 (Wednesday, May 7, 2008)]
[Notices]
[Pages 25769-25770]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-10082]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number 1117-0010]


Agency Information Collection Activities

ACTION: 30-day notice of information collection under review.

-----------------------------------------------------------------------

    Proposed collection; comments requested:

U.S. Official Order Forms for Schedule I and II Controlled Substances 
(Accountable Forms), Order Form Requisition--DEA Form 222 and 222a

    The Department of Justice (DOJ), Drug Enforcement Administration 
(DEA) will be submitting the following information collection request 
to the Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. The proposed 
information collection is published to obtain comments from the public 
and affected agencies. This proposed information collection was 
previously published in the Federal Register Volume 73, Number 42, page 
11443 on March 3, 2008, allowing for a 60 day comment period.
    The purpose of this notice is to allow for an additional 30 days 
for public comment until June 6, 2008. This process is conducted in 
accordance with 5 CFR 1320.10.
    Written comments and/or suggestions regarding the items contained 
in this notice, especially the estimated public burden and associated 
response time, should be directed to the Office of Management and 
Budget, Office of Information and Regulatory Affairs, Attention 
Department of Justice Desk Officer, Washington, DC 20503. Additionally, 
comments may be submitted to OMB via facsimile to (202) 395-5806.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:

    --Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    --Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    --Enhance the quality, utility, and clarity of the information to 
be collected; and

[[Page 25770]]

    --Minimize the burden of the collection of information on those who 
are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

Overview of This Information Collection

    (1) Type of Information Collection: Extension of a currently 
approved collection.
    (2) Title of the Form/Collection: U.S. Official Order Forms for 
Schedule I and II Controlled Substances (Accountable Forms), Order Form 
Requisition (DEA Form 222 and 222a).
    (3) Agency form number, if any, and the applicable component of the 
Department sponsoring the collection:
    Form number: DEA Form 222 and 222a.
    Component: Office of Diversion Control, Drug Enforcement 
Administration, Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Primary: Business or other for-profit.
    Other: Not-for-profit, State, local or tribal government.
    Abstract: DEA-222 is used to transfer or purchase Schedule I and II 
controlled substances and data are needed to provide an audit of 
transfer and purchase. DEA-222a Requisition Form is used to obtain the 
DEA-222 Order Form. Persons may also digitally sign and transmit orders 
for controlled substances electronically, using a digital certificate. 
Orders for Schedule I and II controlled substances are archived and 
transmitted to DEA.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: DEA estimates 
that 96,280 registrants submit forms annually for this collection, 
taking an estimated 13.34 hours annually.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: DEA estimates that there will be 1,283,935 annual 
burden hours associated with the collection.
    If additional information is required contact: Lynn Bryant, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Patrick Henry 
Building, Suite 1600, 601 D Street, NW., Washington, DC 20530.

    Dated: May 2, 2008.
Lynn Bryant,
Department Clearance Officer, PRA, U.S. Department of Justice.
 [FR Doc. E8-10082 Filed 5-6-08; 8:45 am]
BILLING CODE 4410-09-P